FOXA1 Leads to Aberrant Expression of SIX4 Affecting Cervical Cancer Cell Growth and Chemoresistance

Cervical cancer (CC) is among the most prevalent cancers among female populations with high recurrence rates all over the world. Cisplatin (DDP) is the first-line treatment for multiple cancers, including CC. The main problem associated with its clinical application is drug resistance. This study is...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhuo, Sun, Bao-Sheng, Chen, Zhi-Shen, Zhao, Kang-Kang, Wang, Yun-Long, Meng, Fan-Xu, Zhang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045987/
https://www.ncbi.nlm.nih.gov/pubmed/35498155
http://dx.doi.org/10.1155/2022/9675466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045987/
https://www.ncbi.nlm.nih.gov/pubmed/35498155
http://dx.doi.org/10.1155/2022/9675466

Ejemplares similares